2/4/2021Wyeth Wins Trademark Infringement and Unfair Competition Lawsuit in C...

2/4/2021Xuanzhu Pharma Takes Over Combio to Expand Biologics Pipeline

2/4/2021Boehringer Sues China's Qilu Pharma in the U.S. over Patent Infringeme...

2/4/2021Changes To Biotech And Chemical Patent Examination - Recent Amendments...

2/3/2021AJMC: China Pulls Out Stops for Biosimilar Development

2/3/2021Illumina and Sequoia Capital China Announce Deal to Incubate Genomics...

2/3/2021NMPA Publicizes the List of Reference Formulations for GQCE Studies (4...

2/3/2021Bayer's NDA for Finerenone Accepted in China

2/3/2021Amgen/Celgene's NDA for Apremilast Accepted in China

2/3/2021MNCs Secure Multiple New Drug Approvals in China

2/3/2021Bayer's Nexavar Composition Patent Challenged and Invalidated in China

2/2/2021More A Share-Listed Chinese MedPharm Cos Report 2020 Performance Guida...

2/2/2021Harbour BioMed and ProBioGen Agree on a GlymaxX License to Fast-Track ...

2/2/2021Astellas Granted Chinese Approval of XOSPATA (Gilteritinib)

2/2/2021WuXi STA to Acquire BMS's Manufacturing Facility in Couvet, Switzerlan...

2/2/2021Eli Lilly Reports 2020 Performance/2021 Outlook, Highlighting Volume G...

2/2/2021Innovent and Lilly Announce Chinese Approval of TYVYT Combo for nsq...

2/2/2021AZ's Chinese Partner Kangtai Bio Expects to Make 400M COVID-19 Vaccine...

2/2/2021Bayer: Successfully Protected Legal Rights of "Kangwang" Trademark

2/1/2021NHSA Issues Two Documents for Inter-provincial Direct Settlement of BM...

2/1/2021CDE Issues the Technical Guidelines for Clinical Trials of Therapeutic...

2/1/2021GSK Ends COVID-19 Vaccine Partnership with Clover

2/1/2021Coherus and Junshi Enter Licensing Deal for Toripalimab in North Ameri...

2/1/2021Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of...

2/1/2021Legend Biotech Announces BCMA CAR-T Cilta-cel Accepted for Accelerated...

2/1/2021Antengene Partners with WuXi Biologics / WuXi STA to Advance Antibody-...

2/1/2021China Unveils Action Plan on Building High-Standard Market System with...

1/29/2021Ascentage Granted Orphan Drug Designation to Bcl-2 Inhibitor APG-2575 ...

1/29/2021CDE Issues the Guideline on Adaptive Designs for Clinical Trials

1/29/2021Recent Executive Moves

Page:145/719 Total number of articles:21555: [First][<<] [143] [144] [145] [146] [147] [>>] [End]